Company Filing History:
Years Active: 2010
Title: Christopher V Van Hout: Innovator in Polymerase Inhibition
Introduction
Christopher V Van Hout is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of nucleic acid amplification through his innovative work on polymerase inhibitors. His research focuses on enhancing the efficiency of nucleic acid amplification reactions, which are crucial in various biotechnological applications.
Latest Patents
Christopher holds a patent for a "Polymerase inhibitor and method of using same." This invention provides nucleic acid-based polymerase inhibitors designed to reduce non-specific polymerase extension and amplification in nucleic acid amplification reactions. The polymerase inhibitors feature a double-stranded nucleic acid portion that is recognized by a polymerase enzyme as a template for extension but cannot be extended by the enzyme. The polymerase binds to the inhibitor, which sequesters the enzyme until the temperature reaches a level that denatures the double-stranded portion of the inhibitor. After this, the polymerase is released and can catalyze nucleic acid extension.
Career Highlights
Christopher is currently employed at Eragen Biosciences, Inc., where he continues to advance his research in the field of molecular biology. His work has implications for improving the accuracy and efficiency of genetic testing and research.
Collaborations
Some of his notable coworkers include Michael James Moser and David J Marshall, who contribute to the collaborative environment at Eragen Biosciences, Inc. Their combined expertise fosters innovation and drives the development of new technologies in the field.
Conclusion
Christopher V Van Hout is a distinguished inventor whose work on polymerase inhibitors has the potential to significantly impact the field of nucleic acid amplification. His contributions are vital for advancing biotechnological applications and improving genetic research methodologies.